Hyperaemic microvascular resistance is not increased in viable myocardium after chronic myocardial infarction

European Heart Journal

Volumn 28, Issue 19, 2007, Pages 2320-2325

  Marques, Koen M ^a   Knaapen, Paul ^a   Boellaard, Ronald ^a   Westerhof, Nico ^a   Lammertsma, Adriaan A ^a   Visser, Cees A ^a   Visser, Frans C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Infraction; Microcirculation; Physiology; Regional myocardial blood flow

Indexed keywords

ADULT; ARTICLE; BLOOD FLOWMETRY; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL ARTICLE; CORONARY ARTERY PRESSURE; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART MUSCLE; HUMAN; HYPERAEMIC MICROVASCULAR RESISTANCE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; SCINTIGRAPHY;

AGED; BLOOD FLOW VELOCITY; CHRONIC DISEASE; CORONARY CIRCULATION; CORONARY STENOSIS; FEMALE; HUMANS; HYPEREMIA; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; PRESSURE; VASCULAR RESISTANCE;

EID: 35148843326     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm309     Document Type: Article

References (43)

1. Abularrage CJ, Sidawy AN, Aidinian G, Singh N, Weiswasser JM, Arora S. Evaluation of the microcirculation in vascular disease. J Vasc Surg 2005;42:574-581.
2. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356:830-840.
3. Clark MG, Barrett EJ, Wallis MG, Vincent MA, Rattigan S. The microvasculature in insulin resistance and type 2 diabetes. Semin Vasc Med 2002;2:21-31.
4. Ito H, Terai K, Iwakura K, Kawase I, Fujii K. Hemodynamics of microvascular dysfunction in patients with anterior wall acute myocardial infarction. Am J Cardiol 2004;94:209-212.
5. Motz W, Vogt M, Strauer BE. Coronary microcirculation in hypertensive heart disease: functional significance and therapeutic implications. Clin Investig 1993;71(Suppl. 5):S42-S45.
6. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985;312:932-936.
7. 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998;97:2302-2306.
8. Bremerich J, Wendland MF, Arheden H, Wyttenbach R, Gao DW, Huberty JP, Dae MW, Higgins CB, Saeed M. Microvascular injury in reperfused infarcted myocardium: noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging. J Am Coll Cardiol 1998;32:787-793.
9. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879-888.
10. Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 2002;105:1909-1913.
11. Ito H, Okamura A, Iwakura K, Masuyama T, Hori M, Takiuchi S, Negoro S, Nakatsuchi Y, Taniyama Y, Higashino Y, Fujii K, Minamino T. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996;93:1993-1999.
12. Kamp O, Lepper W, Vanoverschelde JL, Aeschbacher BC, Rovai D, Assayag P, Voci P, Kloster Y, Distante A, Visser CA. Serial evaluation of perfusion defects in patients with a first acute myocardial infarction referred for primary PTCA using intravenous myocardial contrast echocardiography. Eur Heart J 2001;22:1485-1495.
13. Kondo M, Nakano A, Saito D, Shimono Y. Assessment of 'microvascular no-reflow phenomenon' using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction. J Am Coll Cardiol 1998;32:898-903.
14. Lepper W, Hoffmann R, Kamp O, Franke A, de Cock CC, Kuhl HP, Sieswerda GT, Dahl J, Janssens U, Voci P, Visser CA, Hanrath P. Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angioplasty [correction of angiography] in patients with acute myocardial infarction. Circulation 2000;101:2368-2374.
15. Maes A, Van de WF, Nuyts J, Bormans G, Desmet W, Mortelmans L. Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up. Circulation 1995;92:2072-2078.
16. Mazur W, Bitar JN, Lechin M, Grinstead WC, Khalil AA, Khan MM, Sekili S, Zoghbi WA, Raizner AE, Kleiman NS. Coronary flow reserve may predict myocardial recovery after myocardial infarction in patients with TIMI grade 3 flow. Am Heart J 1998;136:335-344.
17. Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A. Delayed recovery of coronary resistive vessel function after coronary angioplasty. J Am Coll Cardiol 1993;21:612-621.
18. Claeys MJ, Bosmans JM, Hendrix J, Vrints CJ. Reliability of fractional flow reserve measurements in patients with associated microvascular dysfunction: importance of flow on translesional pressure gradient. Catheter Cardiovasc Interv 2001;54:427-434.
19. Aarnoudse W, Fearon WF, Manoharan G, Geven M, Van DV, Rutten M, de Bruyne B, Pijls NH. Epicardial stenosis severity does not affect minimal microcirculatory resistance. Circulation 2004;110:2137-2142.
20. Sambuceti G, Marzilli M, Fedele S, Marini C, L'Abbate A. Paradoxical increase in microvascular resistance during tachycardia downstream from a severe stenosis in patients with coronary artery disease: reversal by angioplasty. Circulation 2001;103:2352-2360.
21. Meuwissen M, Chamuleau SA, Siebes M, Schotborgh CE, Koch KT, de Winter RJ, Bax M, de Jong A, Spaan JA, Piek JJ. Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions. Circulation 2001;103:184-187.
22. Chamuleau SA, Siebes M, Meuwissen M, Koch KT, Spaan JA, Piek JJ. Association between coronary lesion severity and distal microvascular resistance in patients with coronary artery disease. Am J Physiol Heart Circ Physiol 2003;285:H2194-H2200.
23. Araujo LI, Lammertsma AA, Rhodes CG, McFalls EO, Iida H, Rechavia E, Galassi A, de Silva R, Jones T, Maseri A. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 1991;83:875-885.
24. Iida H, Tamura Y, Kitamura K, Bloomfield PM, Eberl S, Ono Y. Histochemical correlates of (15)O-water-perfusable tissue fraction in experimental canine studies of old myocardial infarction. J Nucl Med 2000;41:1737-1745.
25. Knaapen P, Boellaard R, Gotte MJ, Dijkmans PA, van Campen LM, de Cock CC, Luurtsema G, Visser CA, Lammertsma AA, Visser FC. Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy. J Nucl Med 2004;45:1299-1304.
26. Hermansen F, Rosen SD, Fath-Ordoubadi F, Kooner JS, Clark JC, Camici PG, Lammertsma AA. Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols. Eur J Nucl Med 1998;25:751-759.
27. Yamamoto Y, de Silva R, Rhodes CG, Araujo L, Iida H. A new strategy for the assessment of viable myocardium and regional myocardial blood flow using 15O-water and dynamic positron emission tomography. Circulation 1992;86:167-178.
28. de Silva R, Yamamoto Y, Rhodes CG, Iida H, Nihoyannopoulos P, Davies GJ, Lammertsma AA, Jones T, Maseri A. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 1992;86:1738-1742.
29. Itoh H, Namura M, Seki H, Asai T, Tsuchiya T, Uenishi H, Fujii H, Fujita S, Tanabe Y, Ito J, Shimizu M, Mabuchi H. Perfusable tissue index obtained by positron emission tomography as a marker of myocardial viability in patients with ischemic ventricular dysfunction. Circ J 2002;66:341-344.
30. Bol A, Melin JA, Vanoverschelde JL, Baudhuin T, Vogelaers D, De Pauw M, Michel C, Luxen A, Labar D, Cogneau M. Direct comparison of [13N]ammonia and [15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres. Circulation 1993;87:512-525.
31. Klein LW, Agarwal JB, Schneider RM, Hermann G, Weintraub WS, Helfant RH. Effects of previous myocardial infarction on measurements of reactive hyperemia and the coronary vascular reserve. J Am Coll Cardiol 1986;8:357- 363.
32. Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 1994;331:222-227.
33. Mintz GS, Painter JA, Pichard AD, Kent KM, Satler LF, Popma JJ, Chuang YC, Bucher TA, Sokolowicz LE, Leon MB. Atherosclerosis in angiographically 'normal' coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995;25:1479-1485.
34. de Bruyne B, Hersbach F, Pijls NH, Bartunek J, Bech JW, Heyndrickx GR, Gould KL, Wijns W. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but 'normal' coronary angiography. Circulation 2001;104:2401-2406.
35. Chareonthaitawee P, Kaufmann PA, Rimoldi O, Camici PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 2001;50:151-161.
36. Vanhaecke J, Flameng W, Borgers M, Jang IK, Van de WF, De Geest H. Evidence for decreased coronary flow reserve in viable postischemic myocardium. Circ Res 1990;67:1201-1210.
37. Prech M, Grajek S, Marszalek A, Lesiak M, Jemielity M, Araszkiewicz A, Mularek-Kubzdela T, Cieslinski A. Chronic infarct-related artery occlusion is associated with a reduction in capillary density. Effects on infarct healing. Eur J Heart Fail 2006;8:373-380.
38. Chen JW, Ting CT, Chen YH, Wu TC, Hsu NW, Lin SJ, Chang MS. Differential coronary microvascular function in patients with left ventricular dysfunction of unknown cause-implication for possible mechanism of myocardial ischemia in early stage of cardiomyopathy. Int J Cardiol 1999;69:251-261.
39. de Bruyne B, Pijls NH, Bartunek J, Kulecki K, Bech JW, De Winter H, Van Crombrugge P, Heyndrickx GR, Wijns W. Fractional flow reserve in patients with prior myocardial infarction. Circulation 2001;104:157-162.
40. Usui Y, Chikamori T, Yanagisawa H, Morishima T, Hida S, Tanaka N, Takazawa K, Yamashina A. Reliability of pressure-derived myocardial fractional flow reserve in assessing coronary artery stenosis in patients with previous myocardial infarction. Am J Cardiol 2003;92:699-702.
41. de Bruyne B, Pijls NH, Barbato E, Bartunek J, Bech JW, Wijns W, Heyndrickx GR. Intracoronary and intravenous adenosine 5′-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation 2003;107:1877-1883.
42. Pijls NH, van Son JA, Kirkeeide RL, de Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993;87:1354-1367.
43. Sambuceti G, Marzilli M, Mari A, Marini C, Schluter M, Testa R, Papini M, Marraccini P, Ciriello G, Marzullo P, L'Abbate A. Coronary microcirculatory vasoconstriction is heterogeneously distributed in acutely ischemic myocardium. Am J Physiol Heart Circ Physiol 2005;288:H2298-H2305.